FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
DOPAR
levodopa
LOE Approaching
Takeda
ORAL · TABLET
Parkinson's disease
1970
NDA30/100
DOPRAM
doxapram hydrochloride
LOE Approaching
Hikma
INJECTION · INJECTABLE
depressionchronic obstructive pulmonary disease
1965
NDA30/100
DORIBAX
doripenem
LOE Approaching
Shionogi
INTRAVENOUS · INJECTABLE
2007
NDA30/100
DORIDEN
glutethimide
LOE Approaching
Sanofi
ORAL · CAPSULE
1957
NDA30/100
DORYX
doxycycline hyclate
LOE Approaching
ORAL · CAPSULE, DELAYED RELEASE
Rocky Mountain spotted fevertyphus fever+19
1985
NDA30/100
DOSTINEX
cabergoline
LOE Approaching
Pfizer
ORAL · TABLET
hyperprolactinemic disorderseither idiopathic+1
1996
NDA30/100
DOTAREM
gadoterate meglumine
Peak
Guerbet
INTRAVENOUS · SOLUTION
2013
NDA30/100
DOVONEX
calcipotriene
LOE Approaching
Leo Pharma
TOPICAL · OINTMENT
plaque psoriasis in adultspsoriasis
1993
NDA30/100
DOVONEX
calcipotriene
LOE Approaching
Leo Pharma
TOPICAL · CREAM
plaque psoriasispsoriasis
1996
NDA30/100
DOVONEX
calcipotriene
LOE Approaching
PleoPharma
TOPICAL · SOLUTION
plaque psoriasispsoriasis
1997
NDA30/100
DOXEPIN HYDROCHLORIDE
doxepin hydrochloride
LOE Approaching
ORAL · CAPSULE
major depressive disorder (MDD) in adults ( )
1972
NDA30/100
DOXERCALCIFEROL
doxercalciferol
Peak
Pfizer
INJECTION · INJECTABLE
secondary hyperparathyroidism in adult patients with Stage 3Stage 4 chronic kidney disease (CKD)+1
2018
NDA30/100
DOXIL (LIPOSOMAL)
doxorubicin hydrochloride liposome
LOE Approaching
Baxter
INJECTION · INJECTABLE, LIPOSOMAL
recurred after platinum-based chemotherapyAIDS-related Kaposi's sarcoma in patients after failure of prior systemic chemotherapy+3
1995
NDA30/100
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
recurred after platinum-based chemotherapyAIDS-related Kaposi's sarcoma in patients after failure of prior systemic chemotherapy+3
1974
NDA30/100
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
breast cancerleukemia+1
1987
NDA30/100
DRAX EXAMETAZIME
kit for the preparation of technetium tc 99m exametazime for leukocyte labeling
Peak
Jubilant Therapeutics
INTRAVENOUS · POWDER
2017
NDA30/100
DRAXIMAGE DTPA
kit for the preparation of technetium tc 99m pentetate
LOE Approaching
Jubilant Therapeutics
INJECTION · INJECTABLE
pulmonary embolism
1989
NDA30/100
DRAXIMAGE MDP-10
technetium tc 99m medronate
LOE Approaching
Jubilant Therapeutics
INJECTION · INJECTABLE
1978
NDA30/100
DRAXIMAGE MDP-25
technetium tc 99m medronate
LOE Approaching
Jubilant Therapeutics
INJECTION · INJECTABLE
1978
NDA30/100
DRISDOL
ergocalciferol
LOE Approaching
ORAL · CAPSULE
1941
NDA30/100
DRIXORAL
dexbrompheniramine maleate; pseudoephedrine sulfate
LOE Approaching
Merck & Co.
ORAL · TABLET, EXTENDED RELEASE
nasal congestion due to the common coldhay fever+6
1963
NDA30/100
DRIXORAL PLUS
acetaminophen; dexbrompheniramine maleate; pseudoephedrine sulfate
LOE Approaching
Merck & Co.
ORAL · TABLET, EXTENDED RELEASE
minor achespains due to: headache sore throat flu toothache the common cold temporarily reduces fever
1987
NDA30/100
DROXIA
hydroxyurea
LOE Approaching
Viatris (2)
ORAL · CAPSULE
frequency of painful crisesto reduce the need for blood transfusions in patients with sickle cell anemia with recurrent moderate to severe painful crises+1
1967
NDA30/100
DRYTEC
technetium tc-99m sodium pertechnetate generator
LOE Approaching
INTRAVENOUS, ORAL · SOLUTION
1976
NDA30/100